Company Name: |
3B Pharmachem (Wuhan) International Co.,Ltd.
|
Tel: |
821-50328103-801 18930552037 |
Email: |
3bsc@sina.com |
Products Intro: |
Product Name:SB 221284;2,3-Dihydro-5-(Methylthio)-N-3-pyridinyl-6-(trifluoroMethyl)-1H-indole-1-carboxaMide CAS:196965-14-7 Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
|
Company Name: |
EMMX Biotechnology LLC
|
Tel: |
888-539-0666 |
Email: |
info@emmx.com |
Products Intro: |
Product Name:SB 221284 CAS:196965-14-7 Purity:98% HPLC Package:5mg;10mg;25mg;50mg;100mg;250mg;500mg;1g
|
Company Name: |
BOC Sciences
|
Tel: |
|
Email: |
info@bocsci.com |
Products Intro: |
Product Name:SB 221284 CAS:196965-14-7 Purity:≥99% by HPLC Remarks:SB 221284 is a potent and selective 5-HT2C/2B receptor antagonist (pKi = 6.4, 7.9 and 8.6 for 5-HT2A, 2B and 2C receptors, respectively).
|
|
| SB 221284 Basic information |
Product Name: | SB 221284 | Synonyms: | 5-(METHYLTHIO)-1-(3-PYRIDYLCARBAMOYL)-6-(TRIFLUOROMETHYL)INDOLINE;2,3-DIHYDRO-5-(METHYLTHIO)-N-3-PYRIDINYL-6-(TRIFLUOROMETHYL)-1H-INDOLE-1-CARBOXAMIDE;SB 221284;1H-Indole-1-carboxamide, 2,3-dihydro-5-(methylthio)-N-3-pyridinyl-6-(trifluoromethyl)- | CAS: | 196965-14-7 | MF: | C16H14F3N3OS | MW: | 353.36 | EINECS: | | Product Categories: | | Mol File: | 196965-14-7.mol | ![SB 221284 Structure](CAS/GIF/196965-14-7.gif) |
| SB 221284 Chemical Properties |
Melting point | 262-264 °C | Boiling point | 536.2±50.0 °C(Predicted) | density | 1.43±0.1 g/cm3(Predicted) | storage temp. | Store at +4°C | solubility | DMSO: ~14 mg/mL, soluble | form | solid | pka | 13.13±0.20(Predicted) | color | white |
| SB 221284 Usage And Synthesis |
Uses | SB 221284 is a potent, selective SR-2C/SR-2B antagonist. | Definition | ChEBI: SB 221284 is an indolyl carboxylic acid. | Biological Activity | Potent, selective 5-HT 2C/2B receptor antagonist. pK i values are 6.4, 7.9 and 8.6 for 5-HT 2A , 2B and 2C receptors respectively. Centrally active upon systemic administration in vivo . |
| SB 221284 Preparation Products And Raw materials |
|